Device Trial Radar · NCT05568069
RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure
Last checked: Nov 20, 2026Latest source record: Jun 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,504
Planned (sponsor's estimate)
Start
Apr 12, 2023
Primary completion
Feb 28, 2029
Study completion Feb 28, 2032
Sponsor
- Lead sponsor
- University Hospital Southampton NHS Foundation TrustAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- British Heart Foundation; University of Southampton
- First posted
- Oct 5, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
BRITISH is a UK multicentre trial of patients who have been diagnosed with heart failure due to Non-Ischemic Cardiomyopathy (NICM, or heart failure that is not caused by blocked heart arteries. Participants will be randomised into two groups. Half the participants will receive an Implantable Cardioverter-Defibrillator (ICD) and the other half will not. The aim of the study will be to compare all-cause mortality (death from any cause) between these two groups at 36 months, and longer-term to 10 years. The study has the potential to change international heart failure treatment guidelines and to improve how patients with this condition are managed.
Conditions
- Heart Failure
Interventions
Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronisation Therapy Defibrillator (CRTD)Device
An ICD is a device that is implanted under the skin under a local anesthetic. It has a battery/generator component and leads which are fixed into the heart chambers. It has the ability to detect dangerous heart rhythms if they occur, and deliver a shock to treat this to help prevent sudden cardiac death. A CRTD is a pacemaker with a defibrillator function.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of patients aliveTime frame: 3 years
Locations
47 sites in 1 country. Site status is shown where the registry gives one.
Royal Devon & Exeter Hospital
Exeter, United Kingdom · Recruiting
Morriston Hospital
Swansea, United Kingdom · Recruiting
Wycombe Hospital
High Wycombe, Buckinghamshire, United Kingdom · Recruiting
44 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.